Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ebos GroupEBOSY 85 EV-to-OCF is 20.94 as of Jul. 30, 2026, which is 3% below its 10-year median of 21.49. GuruFocus rates EBOSY with a GF Score™ of 85/100 and a GF Value™ of $47.52. The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Ebos Group ranks worse than 77.31% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ebos Group's Enterprise Value is $3,699 Mil.
Ebos Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $177 Mil. Therefore, Ebos Group's EV-to-OCF for today is 20.94.
The historical rank and industry rank for Ebos Group's EV-to-OCF or its related term are showing as below:
EBOSY'
s EV-to-OCF Range Over the Past 10 Years
Min: 11.95 Med: 21.49 Max: 34.21
Current: 21.37
During the past 13 years, the highest EV-to-OCF of Ebos Group was 34.21. The lowest was 11.95. And the median was 21.49.
EBOSY's EV-to-OCF is ranked worse than 77.31% of 119
companies
in the Medical Distribution industry
Industry Median: 8.26
vs EBOSY: 21.37
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ebos Group's share price for today is $26.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $1.472.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ebos Group EV-to-OCF Related Terms
Ebos Group EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Ebos Group's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ebos Group's EV-to-OCF falls into.
Ebos Group's current Enterprise Value is $3,699 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ebos Group's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $177 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group (EBOSY) has a EV-to-OCF of 20.94 as of Jul. 30, 2026. This is near median its historical median of 21.49. Over the past decade, Ebos Group's EV-to-OCF has ranged from 11.95 to 34.21. According to the industry distribution chart, Ebos Group ranks #92 out of 119 companies in the Medical Distribution industry, placing it in the top 77.3%.
Is Ebos Group's EV-to-OCF too high?
Ebos Group's current EV-to-OCF of 20.94 is near median its 10-year median of 21.49. Over the past 10 years, this metric has ranged from a low of 11.95 to a high of 34.21. The Medical Distribution industry median EV-to-OCF is 8.26. Ebos Group's value of 20.94 is 153.5% above this industry median. Based on the distribution chart, Ebos Group ranks #92 out of 119 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Ebos Group has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #92 out of 119 companies for EV-to-OCF. This places Ebos Group in the lower half of its industry. The industry median EV-to-OCF is 8.26. Ebos Group's value of 20.94 is 153.5% above this benchmark. Historically, Ebos Group's own EV-to-OCF has ranged from 11.95 to 34.21 over the past decade. While the company's 10-year median is 21.49 vs. the industry median of 8.26, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 8.26, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current EV-to-OCF of 20.94 is 153.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 8.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current EV-to-OCF is 20.94, which is near median its own 10-year median of 21.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Ebos Group (EBOSY) has a current EV-to-OCF of 20.94. The stock's GF Value™ is $47.52, compared to a current price of $26.00 — trading 45.3% below its estimated fair value. The current EV-to-OCF is 20.94, which is near median its 10-year median of 21.49 and 153.5% above the Medical Distribution industry median of 8.26. Ebos Group's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ebos Group (EBOSY), the current EV-to-OCF is 20.94 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (EBOSY) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of $26.00 is trading 45.3% below its estimated GF Value™ of $47.52.
Key valuation signals for EBOSY:
EV-to-OCF: 20.94 (near median its 10-year median of 21.49)
GF Value™: $47.52 vs. price of $26.00 (45.3% below fair value)
Industry Position: 153.5% above the Medical Distribution median (#92 of 119)
No single metric tells the full story. See the EBOSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
85GF Score
Get the complete analysis for EBOSY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBOSY has been successfully added to your 
